DB
Darpana Baruah
About Darpana Baruah
Data last updated:
Darpana Baruah has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Exsiva Associates Private Limited and Exsiva Pharma Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Exsiva Pharma Private Limited at ₹5.55 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 May 2016 | 2016 | ₹5.55 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Nov 2018 | 2018 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Darpana Baruah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Darpana Baruah
Darpana Baruah has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Exsiva Associates Private Limited and Exsiva Pharma Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Exsiva Pharma Private Limited at ₹5.55 Cr (FY 2025).
Darpana Baruah is associated with 1 company as Director, including Exsiva Pharma Private Limited (₹5.55 Cr).
Darpana Baruah has expertise in General Business.
Darpana Baruah has 10 years in corporate governance.
By reported revenue, the largest current company of Darpana Baruah is Exsiva Pharma Private Limited, with revenue of ₹5.55 Cr (FY 2025).
Darpana Baruah currently holds positions at 1 company: Exsiva Pharma Private Limited (₹5.55 Cr).